Alan velasquez
:
Jaguar Health, Inc. stockholders approved all four proposals during a special meeting on April 9, 2024, including a reverse stock split to meet Nasdaq’s minimum bid price requirement and the issuance of common stock upon the exchange of Series J Preferred Stock. The company had previously received a delisting warning from Nasdaq due to its stock price falling below $1.00, and a subsequent delisting determination letter when the bid price dropped to $0.10. Jaguar Health has been granted an extension until August 13, 2024, to regain compliance with Nasdaq’s listing rules.
Alan velasquez : RS they reject the RS until August read the news
Rockhoundj : You have zero basis for such a claim
R/s was voted no
And an offering would definitely ensure non-compliance
Alan velasquez : Jaguar Health, Inc. stockholders approved all four proposals during a special meeting on April 9, 2024, including a reverse stock split to meet Nasdaq’s minimum bid price requirement and the issuance of common stock upon the exchange of Series J Preferred Stock. The company had previously received a delisting warning from Nasdaq due to its stock price falling below $1.00, and a subsequent delisting determination letter when the bid price dropped to $0.10. Jaguar Health has been granted an extension until August 13, 2024, to regain compliance with Nasdaq’s listing rules.
Rockhoundj Alan velasquez : That’s my mistake! Should have went back to check the most recent news
Cardinal-BagHolder : I’ll go RS but absolutely no offering. None! Trying shorting that MFS!